Document:

Exhibit 10.70

 

 

FOURTH AMENDMENT TO NOTE AND WARRANT
PURCHASE AGREEMENT, LIMITED CONSENT AND LIMITED WAIVER

 

This FOURTH AMENDMENT
TO NOTE AND WARRANT AGREEMENT, LIMITED CONSENT AND LIMITED WAIVER (this “Amendment”), dated as of June 30, 2015,
is made by and between TWINLAB CONSOLIDATED HOLDINGS, INC., a Nevada corporation (“Parent”), TWINLAB CONSOLIDATION
CORPORATION, a Delaware corporation (“TCC”), TWINLAB HOLDINGS, INC., a Michigan corporation (“Twinlab
Holdings”), ISI BRANDS INC., a Michigan corporation (“ISI Brands”), and TWINLAB CORPORATION, a Delaware
corporation (“Twinlab Corporation”), NUTRASCIENCE LABS, INC., a Delaware corporation, NUTRASCIENCE LABS IP CORPORATION.,
a Delaware corporation (each of the foregoing Persons being referred to herein individually as a “Company” and
collectively as the “Companies”), and PENTA MEZZANINE SBIC FUND I, L.P., a Delaware limited partnership (the
“Purchaser”).

 

WHEREAS, the Companies
and the Purchaser are parties to a Note and Warrant Purchase Agreement dated as of November 13, 2014, as amended by that certain
First Amendment to Note and Warrant Purchase Agreement, Consent and Joinder dated as of January 22, 2015, that certain Second Amendment
to Note and Warrant Purchase Agreement and Consent dated as of February 4, 2015 and that certain Third Amendment to Note and Warrant
Purchase Agreement and Consent dated as of April 30, 2015 (as the same may be further amended, restated, amended and restated,
supplemented or otherwise modified from time to time, the “Note Purchase Agreement”); and

 

WHEREAS, the Companies
have requested that the Purchaser convert the aggregate amount of interest payable on the Notes for the period beginning on May
1, 2015 and ending on October 31, 2015 (it being understood and agreed that the aggregate amount of interest payable for such period
is $613,333) into Equity Interests in Parent at the price of $0.76 per share of common stock pursuant to that certain Share Purchase
Agreement, dated as of the date hereof, among Purchaser and Parent (the “Share Purchase Agreement”) (the “Interest
Conversion”);

 

WHEREAS, (a) the Companies
have requested that the Purchaser (i) consent to the Interest Conversion and (ii) waive certain defaults and provisions of the
Note Purchase Agreement, and (b) the Purchaser has agreed to do so subject to the terms and conditions set forth herein.

 

NOW, THEREFORE, in
consideration of the promises and the mutual agreements contained in this Amendment, and subject to the terms and conditions set
forth herein, each party hereto hereby agrees as follows:

 

1.          Capitalized
Terms. Capitalized terms used but not defined herein shall have the meanings set forth in the Note Purchase Agreement.

 

2.          Limited
Consent for the Interest Conversion. At the request of and as an accommodation to the Companies and subject to the strict compliance
with the terms, conditions and requirements set forth herein (including, without limitation, satisfaction of each of the conditions
set forth in Section 8 below), the Purchaser hereby consents to the Interest Conversion. The limited consent set forth in this
Section 2 is effective solely for the purposes set forth herein and shall be limited precisely as written and shall not be deemed
to (a) except as expressly provided herein, be a consent to any amendment, waiver or modification of any term or condition of the
Note Purchase Agreement or of any other Transaction Document; (b) prejudice any right that the Purchaser have or may have in the
future under or in connection with the Note Purchase Agreement or any other Transaction Document; (c) waive any Event of Default
that exists as of the date hereof; or (d) establish a custom or course of dealing among any of the Companies, on the one hand,
or the Purchaser on the other hand.

 

    	1

    	 

    

  

3.          Limited
Consent for new Essex Lease. At the request of and as an accommodation to the Companies and subject to the strict compliance
with the terms, conditions and requirements set forth herein (including, without limitation, satisfaction of each of the conditions
set forth in Section 8 below), the Purchaser hereby consents to (i) a sale/leaseback and refinancing transaction with Essex Capital
Corporation in the principal rental amount of $2,750,000 consisting of the sale/leaseback of existing Twinlab Corporation equipment
described on Exhibit K (the “First 2015 Essex Lease”) and (ii) a sale/leaseback and refinancing transaction
with Essex Capital Corporation in the principal rental amount of $150,000 consisting of the sale/leaseback of existing Twinlab
Corporation equipment described on Exhibit L (the “Second 2015 Essex Lease” and together, collectively,
the “2015 Essex Leases”). Consent for the 2015 Essex Leases includes consent for Twinlab Corporation to sell
the equipment described on Exhibit K and Exhibit L to Essex Capital Corporation, and the Purchaser shall execute
such lien releases and file such financing amendments to evidence lien releases of the equipment described on Exhibit K
and Exhibit L as reasonably requested by Twinlab Corporation or Essex Capital Corporation. The limited consent set forth
in this Section 3 is effective solely for the purposes set forth herein and shall be limited precisely as written and shall not
be deemed to (a) except as expressly provided herein, be a consent to any amendment, waiver or modification of any term or condition
of the Note Purchase Agreement or of any other Transaction Document; (b) prejudice any right that the Purchaser has or may have
in the future under or in connection with the Note Purchase Agreement or any other Transaction Document; (c) waive any Event of
Default that exists as of the date hereof; or (d) establish a custom or course of dealing among any of the Companies, on the one
hand, or the Purchaser on the other hand.

 

4.          Limited
Waiver to Note Purchase Agreement. At the request of and as an accommodation to the Companies and subject to the strict compliance
with the terms, conditions and requirements set forth herein (including, without limitation, satisfaction of each of the conditions
set forth in Section 8 below), the Purchaser hereby agrees to waive (i) the Event of Default under Section 11.1(c) of the Note
Purchase Agreement due to the Companies’ failure to comply with the financial covenants set forth in Section 5.12 of the
Note Purchase Agreement for the measurement period ending March 31, 2015 (the “Specified Event of Default”)
and (ii) the Companies’ compliance with the financial covenants set forth in Section 5.12 of the Note Purchase Agreement
for the measurement period ending June 30, 2015. The limited waiver set forth in this Section 4 is effective solely for the purposes
set forth herein and shall be limited precisely as written and shall not be deemed to (a) except as expressly provided herein,
be a consent to any amendment, waiver or modification of any term or condition of the Note Purchase Agreement or of any other Transaction
Document; (b) prejudice any right that the Purchaser have or may have in the future under or in connection with the Note Purchase
Agreement or any other Transaction Document; (c) waive any Event of Default (other than the Specified Event of Default) that exists
as of the date hereof; or (d) establish a custom or course of dealing among any of the Companies, on the one hand, or the Purchaser
on the other hand.

 

5.          Amendments
to Note Purchase Agreement. Subject to the satisfaction of the conditions precedent set forth herein and in reliance on the
representations, warranties and covenants of the Companies set forth herein and in the Note Purchase Agreement, each party hereto
hereby agrees that the Note Purchase Agreement be and hereby is, amended as follows:

 

5.1.          
Amendment and Restatement of Existing Defined Terms. Section 1 of the Note Purchase Agreement is hereby amended by amending
and restating each of the following defined terms as follows:

 

    	2

    	 

    

 

“Essex Debt”
means Indebtedness pursuant to (i) that certain Commercial Lease Agreement, dated as of November 13, 2013, between Twinlab Corporation
and Essex Capital Corporation, (ii) that certain Commercial Lease Agreement, dated as of August 21, 2014 (which Commercial Lease
Agreement refreshes and supersedes a Commercial Lease Agreement dated March 19, 2013), between Twinlab Corporation and Essex Capital
Corporation, and (iii) a new sale/leaseback and refinancing agreement to be entered into between Twinlab Consolidation Corporation
and Essex Capital Corporation, in the form previously provided to and approved by the Agent and for which Essex Capital Corporation
has agreed to be subject to an Agreement Regarding Equipment and Lease in form and substance satisfactory to the Purchaser in its
sole discretion; the rental installments of all such lease agreements identified in subclauses (i) through (iii) together is not
to exceed an aggregate principal rental amount of $5,800,000.

 

“Nutricap Seller First
Note” means the Amended and Restated Unsecured Promissory Note dated June 30, 2015 in the form previously approved by
the Purchaser in the principal amount of $2,750,000 issued by Subco I to Nutricap Labs, LLC, a New York limited liability company,
in connection with the Target 2 Acquisition, the principal and interest repayment of which shall have a maturity of January 1,
2016 and bear interest at 8.5% per annum, an executed copy of which has been provided to the Purchaser.

 

5.2.          Amendment
to Section 5.12(a). Section 5.12(a) of the Note Purchase Agreement is hereby amended and restated in its entirety as follows:

 

“(a)          Minimum
Adjusted EBITDA. Commencing with the month ending July 31, 2015 and until such time as all Obligations are paid, satisfied
and discharged in full, the Borrowers shall not, as of the end of any measurement period set forth below, permit the Adjusted EBITDA
for such measurement period to be less than the amount set forth in the table below opposite such measurement period.

 

	Measurement Period
	 	Minimum Adjusted EBITDA	 
	July 1, 2015 to July 31, 2015	 	$	-700,000	 
	August 1, 2015 to August 31, 2015	 	$	-700,000”	 

 

6.          Representations
and Warranties; No Default. Each Company hereby represents and warrants that:

 

6.1.       The
execution, delivery and performance by such Company of this Amendment (a) are within such Company’s corporate or similar
powers and, at the time of execution hereof and have been duly authorized by all necessary corporate and similar action; (b) does
not and will not result, in any breach or default under any other document, instrument or agreement to which a Company or any of
its Subsidiaries is a party or to which a Company or any of its Subsidiaries, the Premises, the Collateral or any of the property
of a Company or any of its Subsidiaries is subject or bound, except for such breaches or defaults which, individually or in the
aggregate, have not had, and would not reasonably be expected to result in, a Material Adverse Effect and (c) will not violate
any applicable law, statute, regulation, rule, ordinance, code, rule or order.

 

6.2.       This
Amendment has been duly executed and delivered for the benefit of or on behalf of each Company and constitutes a legal, valid and
binding obligation of each Company, enforceable against such Company in accordance with its terms except (a) as the same may be
limited by bankruptcy, insolvency, reorganization moratorium or similar laws now or hereafter in effect relating to creditors rights
generally and (b) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to
equitable defenses and to the discretion of the court before which any proceeding therefor may be brought.

 

    	3

    	 

    

  

6.3.          Both
before and after giving effect to this Amendment on the date hereof (a) except as set forth on Schedule A attached hereto,
the representations and warranties of the Companies contained in Section 4.1 of the Note Purchase Agreement and the other Transaction
Documents are true, correct and complete on and as of the date hereof as if made on such date (and to the extent any representations
and warranties shall relate to the Effective Date or another earlier date, such representation and warranties shall be deemed to
be amended to relate to the date hereof), and (b) except as set forth on Schedule B attached hereto, no Default or Event
of Default (other than the Specified Event of Default) has occurred and is continuing.

 

7.          Ratification
and Confirmation. The Companies hereby ratify and confirm all of the terms and provisions of the Note Purchase Agreement and
the other Transaction Documents and agree that all of such terms and provisions, as amended hereby, remain in full force and effect,
except as, and to the extent expressly set forth herein. 

 

8.           Condition
to Effectiveness. The effectiveness of this Amendment shall be subject to the satisfaction of the following conditions precedent:

 

8.1.        The
Purchaser shall have received (i) a fully executed copy of this Amendment, (ii) a fully executed copy of the Share Purchase Agreement
in the form attached hereto as Exhibit A and (iii) the fully executed Warrant No. W-4 in the form attached hereto as Exhibit
B.

 

8.2.        The
Purchaser shall have received (i) fully executed amendments to the documents evidencing the Permitted Senior Debt in the form attached
hereto as Exhibit C and (ii) evidence reasonably satisfactory to the Purchaser that there will be no reduction in the facility
size or the availability formula under the Permitted Senior Debt.

 

8.3.        The
Purchaser shall have received (i) a fully executed amendment to the Subordinated Loan Agreement in the form attached hereto as
Exhibit D, (ii) a fully executed copy of the Share Purchase Agreement, dated as of the date hereof, among Parent and Subordinated
Lender in the form attached hereto as Exhibit E and (iii) a fully executed copy of the Warrant, dated as of the date hereof,
issued by Parent to Subordinated Lender in the form attached hereto as Exhibit F.

 

8.4.        The
Purchaser shall have received (i) evidence reasonably satisfactory to the Purchaser that the David L. Van Andel Trust, under Trust
Agreement dated November 30, 1993 (the “David L. Van Andel Trust”) has invested at least $2,500,000 in cash
in the Equity Interests of Parent, (ii) a fully executed copy of the Share Purchase Agreement, dated as of the date hereof, among
Parent and David L. Van Andel Trust in the form attached hereto as Exhibit G, (iii) evidence that David L. Van Andel Trust
surrendered to Parent that certain Warrant No. 1, dated as of September 5, 2014, issued by TCC to David L. Van Andel and assumed
by Parent on September 16, 2014, and such warrant has been cancelled and (iv) fully executed copies of the Warrants, dated as of
the date hereof, issued by Parent to David L. Van Andel Trust in the forms attached hereto as Exhibit H.

 

8.5.        The
Purchaser shall have received (i) a fully executed copy of the Share Purchase Agreement, dated as of the date hereof, among Parent
and Little Harbor, LLC in the form attached hereto as Exhibit I and (ii) a fully executed copy of the Warrant, dated as
of the date hereof, issued by Parent to Little Harbor, LLC, in the form attached hereto as Exhibit J.

 

    	4

    	 

    

  

8.6.        The
Purchaser shall have received from the Companies executed copies of all documents and agreements relating to the 2015 Essex Leases
and the Nutricap Seller First Note, including, but not limited to, the Payment Guaranty of Essex Capital Corporation and Ralph
T. Iannelli of the Nutricap Seller First Note and each Bill of Sale with respect to the 2015 Essex Leases, duly executed by an
authorized officer of each of the parties thereto.

 

8.7.        The
Companies shall have delivered to the Purchaser a fully executed copy of the Amendment No. 1 to Standstill Agreement, duly executed
by an authorized officer of each of the parties thereto, including but not limited to NUTRICAP LABS, LLC, as junior lender, and
such amendment shall be satisfactory in form and substance to the Purchaser.

 

8.8.        The
Companies shall have delivered to the Purchaser a fully executed Agreement Regarding Equipment and Lease with respect to the 2015
Essex Leases, and such agreement shall be satisfactory in form and substance to the Purchaser.

 

8.9.        All
representations and warranties of the Companies contained herein shall be true and correct in all material respects as of the date
hereof (and such parties’ delivery of their respective signatures hereto shall be deemed to be its certification thereof).

 

8.10.      The
Purchaser shall have received all fees and other amounts due and payable to the Purchaser and its counsel in connection with this
Amendment, and to the extent invoiced, reimbursement or payment of all out-of-pocket expenses required to be reimbursed or paid
by the Companies under the Note Purchase Agreement.

 

9.          Use
of Proceeds. The Companies hereby agree that the proceeds of the Interest Conversion and the other transactions contemplated
by this Amendment shall be used solely to purchase new raw materials for use in the production of the Companies’ higher margin
products.

 

10.         Miscellaneous.

 

10.1.     Except
as otherwise expressly set forth herein, nothing herein shall be deemed to constitute an amendment, modification or waiver of any
of the provisions of the Note Purchase Agreement, the Security Agreement or the other Transaction Documents, all of which remain
in full force and effect as of the date hereof and are hereby ratified and confirmed. Each Company hereby acknowledges and agrees
that nothing contained herein shall be deemed to entitle any Company to consent to, or a waiver, amendment or modification of,
any of the terms, conditions, obligations, covenants or agreements contained in the Transaction Documents in similar or different
circumstances. This Amendment (together with any other document executed in connection herewith) is not intended to be, nor shall
it be construed as, a novation of the Note Purchase Agreement.

 

10.2.     This
Amendment may be executed in any number of counterparts, each of which, when executed and delivered, shall be an original, but
all counterparts shall together constitute one instrument. Delivery of an executed counterpart of a signature page of this Amendment
by facsimile or electronic mail shall be equally effective as delivery of a manually executed counterpart of this Amendment.

 

10.3.     This
Amendment shall be governed by the laws of the State of New York without giving effect to any conflict of law principles and shall
be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.

 

    	5

    	 

    

  

10.4.          The
Companies agree to pay all reasonable expenses, including legal fees and disbursements, incurred by Purchaser in connection with
this Amendment and the transactions contemplated hereby.

 

10.5.          This
Amendment shall be deemed a Transaction Document for all purposes of the Note Purchase Agreement and the other Transaction Documents.
On and after the date hereof, each reference in the Note Purchase Agreement and the other Transaction Documents to the Note Purchase
Agreement, shall mean and be a reference to the Note Purchase Agreement, as modified by this Amendment.

 

10.6.          Each
Company, voluntarily, knowingly, unconditionally and irrevocably, with specific and express intent, for and on behalf of itself
and all of its respective parents, subsidiaries, affiliates, members, managers, predecessors, successors, and assigns, and each
of their respective current and former directors, officers, shareholders, agents, and employees (collectively, “Releasing
Parties”), does hereby fully and completely release, acquit and forever discharge each Indemnified Party of and from
any and all actions, causes of action, suits, debts, disputes, damages, claims, obligations, liabilities, costs, expenses and demands
of any kind whatsoever, at law or in equity, whether matured or unmatured, liquidated or unliquidated, vested or contingent, choate
or inchoate, known or unknown that the Releasing Parties (or any of them) has against the Indemnified Parties (or any of them)
that directly or indirectly arise out of, are based upon or are in any manner connected with any Prior Related Event. “Prior
Related Event” means any transaction, event, circumstance, action, failure to act, occurrence of any type or sort, whether
known or unknown, which occurred, existed, was taken, was permitted or begun in accordance with, pursuant to or by virtue of (a) any
of the terms of this Amendment or any other Transaction Document, (b) any actions, transactions, matters or circumstances
related hereto or thereto, (c) the conduct of the relationship between the Purchaser and any Company, or (d) any other
actions or inactions by the Purchaser, all on or prior to the date hereof. Each Company acknowledges that the foregoing release
is a material inducement to the Purchaser’s decision to enter into this Amendment and to agree to the modifications contemplated
hereunder.

 

[Signature Pages Follow.]

 

    	6

    	 

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Amendment which shall be deemed to be a sealed instrument as of the date first above written.

  

	 	COMPANIES
	 	 
	 	TWINLAB CONSOLIDATED HOLDINGS, INC.
	 	 	 
	 	By:	/s/ Thomas A. Tolworthy
	 	Name:	Thomas A. Tolworthy
	 	Title:	Chief Executive Officer and President
	 	 	 
	 	TWINLAB HOLDINGS, INC.
	 	 	 
	 	By:	/s/ Thomas A. Tolworthy
	 	Name:	Thomas A. Tolworthy
	 	Title:	Chief Executive Officer and President
	 	 	 
	 	TWINLAB CONSOLIDATION CORPORATION
	 	 	 
	 	By:  	/s/ Thomas A. Tolworthy
	 	Name:	Thomas A. Tolworthy
	 	Title:	Chief Executive Officer and President
	 	 	 
	 	TWINLAB CORPORATION
	 	 	 
	 	By:  	/s/ Thomas A. Tolworthy
	 	Name:	Thomas A. Tolworthy
	 	Title:	Chief Executive Officer and President
	 	 	 
	 	ISI BRANDS, INC.
	 	 	 
	 	By:  	/s/ Thomas A. Tolworthy
	 	Name:	Thomas A. Tolworthy
	 	Title:	Chief Executive Officer and President

 

[Signature Page – Fourth Amendment
to Note and Warrant Purchase Agreement, Limited Consent and Limited Waiver]

 

    	 

    	 

    

  

	 	NUTRASCIENCE LABS, INC.
	 	 	 
	 	By:	/s/ Thomas A. Tolworthy
	 	Name:	Thomas A. Tolworthy
	 	Title:	Chief Executive Officer and President
	 	 	 
	 	NUTRASCIENCE LABS IP CORPORATION
	 	 	 
	 	By: 	/s/ Thomas A. Tolworthy
	 	Name:	Thomas A. Tolworthy
	 	Title:	Chief Executive Officer and President

 

[Signature Page – Fourth Amendment
to Note and Warrant Purchase Agreement, Limited Consent and Limited Waiver]

  

    	 

    	 

    

 

	 	PURCHASER:
	 	 
	 	PENTA MEZZANINE SBIC FUND I, L.P.
	 	 
	 	By: Penta Mezzanine SBIC Fund I GP, LLC, its General Partner
	 	 	 
	 	By:	/s/ Rebecca R. Irish
	 	Name:	Rebecca R. Irish
	 	Title:	Authorized MemberExhibit 10.71

 

 

STOCK PURCHASE AGREEMENT

 

THIS STOCK PURCHASE AGREEMENT (this "Agreement"),
dated as of June 30, 2015, is entered into between Twinlab Consolidated Holdings, Inc., a Nevada corporation with its principal
place of business at 632 Broadway, Suite 201, New York, New York 10012 ("Company"), and JL-BBNC Mezz Utah, LLC,
an Alaska limited liability company, with offices at 701 West 8th Street, Suite 1200, Anchorage, AK 99501 ("Purchaser").

 

RECITALS

 

A.           Company
and Purchaser are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506 of Regulation
D (“Regulation D”) as promulgated by the United States Securities and Exchange Commission (the “Commission”)
under the Securities Act.

 

B.           Purchaser
wishes to purchase, and Company wishes to sell, upon the terms and conditions stated in this Agreement, an aggregate of 403,509
shares of common stock, par value $0.001 per share (the “Common Stock”), of Company, at a purchase price of
$0.76 per share (the 403,509 shares of Common Stock to be purchased by Purchaser hereunder are referred to herein as the “Shares”).

 

C.           Contemporaneously
with the execution and delivery of this Agreement, the parties hereto are executing and delivering a Warrant Agreement, substantially
in the form attached hereto as Exhibit A (the “Warrant Agreement”), pursuant to which, among other things, Company
is granting Purchaser the right to purchase an additional 403,509 shares of Common Stock at a price of $0.01 per share.

 

NOW, THEREFORE, in consideration of the mutual
covenants and agreements hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the parties hereto agree as follows:

 

1.          Purchase
and Sale. Subject to the terms and conditions set forth herein, at the Closing (as defined in Section 2), Company shall
issue and sell to Purchaser, and Purchaser shall purchase from Company, the Shares. The aggregate purchase price for the Shares
shall be $306,667.00 (the "Purchase Price"), to be provided by Purchaser in the form of Purchaser’s agreements
set forth in Section 3 hereof.

 

    	 

    	 

    

 

2.           Closing.
Subject to the terms and conditions contained in this Agreement, the purchase and sale of the Shares contemplated hereby shall
take place at a closing (the "Closing") to be held at 10:00 a.m. on June 30, 2015 (the "Closing Date")
at the offices of Wilk Auslander LLP, 1515 Broadway, 43rd Floor, New York, New York 10036, or at such other place or
on such other date as Purchaser and Company may mutually agree upon in writing. At the Closing, Company shall deliver to Purchaser
a stock certificate or certificates evidencing the Shares, and Purchaser shall have delivered to Company the Purchase Price in
the form of Purchaser’s irrevocable agreement provided in Section 3 below to accept the Shares issued by the Company
pursuant hereto in lieu of $306,667.00 worth of periodic interest payments otherwise due Purchaser under that certain Note, dated
January 22, 2015, by and between the Purchaser on the one hand and the Company and its subsidiaries on the other hand (the “Note”).

 

3.           Agreement
to Accept Shares in Lieu of Payments under the Note. Purchaser hereby irrevocably agrees to accept the Shares issued to Purchaser
by Company pursuant to this Agreement in lieu and in complete satisfaction of the obligation of the Borrower (as defined in the
Note) to make six (6) months of interest payments to Purchaser in an aggregate amount equal to the Purchase Price, and representing
the aggregate amount of interest payable on the Note for the period beginning on May 1, 2015 and ending on October 31, 2015. Except
for Purchaser’s agreement, on the terms set forth herein, to accept the Shares issued pursuant to this Agreement in lieu
of cash interest payments otherwise due Purchaser under the Note in an aggregate amount equal to the Purchase Price, nothing herein
is intended to modify in any way the Note, which shall remain in full force and effect.

 

		4.	Closing Deliveries.

 

(a)          On
or prior to the Closing, Company shall issue, deliver or cause to be delivered to Purchaser the following:

 

(i)          this
Agreement, duly executed by Company;

 

(ii)         certificates
representing the Shares; and

 

(iii)        the
Warrant Agreement, duly executed by Company.

 

(b)          On
or prior to the Closing, Purchaser shall deliver or cause to be delivered to Company the following:

 

(i)          this
Agreement, duly executed by Purchaser.

 

		5.	Closing Conditions.

 

(a)          The
obligation of Company to issue and sell the Shares to Purchaser hereunder is subject to the satisfaction of the following conditions
as of the Closing:

 

    	2

    	 

    

 

(i)          the
representations and warranties of Purchaser in Section 7 hereof shall be true and correct on and as of the Closing Date
with the same effect as though made at and as of such date;

 

(ii)         Purchaser
shall have performed and complied in all material respects with all agreements and conditions required by this Agreement to be
performed or complied with by it prior to or on the Closing Date; and

 

(iii)        Purchaser
shall have obtained any and all consents, permits, approvals, registrations and waivers necessary or appropriate for consummation
of the transactions contemplated herein.

 

(b)          The
obligation of Purchaser to purchase the Shares from Company is subject to the satisfaction of the following conditions as of the
Closing:

 

(i)          the
representations and warranties of Company in Section 6 shall be true and correct on and as of the Closing Date with the
same effect as though made at and as of such date;

 

(ii)         Company
shall have performed and complied in all material respects with all agreements and conditions required by this Agreement to be
performed or complied with by it prior to or on the Closing Date; and

 

(iii)        Company
shall have obtained any and all consents, permits, approvals, registrations and waivers necessary or appropriate for consummation
of the transactions contemplated herein.

 

6.           Representations
and Warranties of Company. Company hereby represents and warrants to Purchaser as follows:

 

(a)          Company
is an entity duly incorporated, validly existing and in good standing under the laws of the State of Nevada, with the requisite
corporate power and authority to own or lease and use its properties and assets and to carry on its business as currently conducted.
Company is not in violation of any of the provisions of its articles of incorporation or bylaws. Company is duly qualified to conduct
business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business
conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing,
as the case may be, would not have a Material Adverse Effect. “Material Adverse Effect” means a material adverse
effect on the results of operations, assets, business or financial condition of Company, except that any of the following, either
alone or in combination, shall not be deemed a Material Adverse Effect: (i) effects caused by changes or circumstances affecting
general market conditions in the U.S. economy or which are generally applicable to the industry in which Company operates provided
that such effects are not borne disproportionately by Company, (ii) effects resulting from or relating to the announcement or disclosure
of the sale of the Shares or other transactions contemplated by this Agreement, or (iii) effects caused by any event, occurrence
or condition resulting from or relating to the taking of any action in accordance with this Agreement.

 

    	3

    	 

    

 

(b)          Company
has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement
and otherwise to carry out its obligations hereunder. The execution and delivery of this Agreement by the Company and the consummation
by it of the transactions contemplated hereby (including, but not limited to, the sale and delivery of the Shares) have been duly
authorized by all necessary corporate action on the part of Company, and no further corporate action is required by Company, its
Board of Directors or its stockholders in connection therewith other than in connection with the Required Approvals (as hereinafter
defined). This Agreement has been duly executed by the Company and is the legal, valid and binding obligation of the Company enforceable
against Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’
rights and remedies or by other equitable principles of general application or insofar as indemnification and contribution provisions
may be limited by applicable law.

 

(c)          The
execution, delivery and performance by Company of this Agreement and the consummation by Company of the transactions contemplated
hereby (including, without limitation, the issuance of the Shares) do not and will not (i) conflict with or violate any provisions
of Company’s articles of incorporation or bylaws or otherwise result in a violation of the organizational documents of Company,
(ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under,
result in the creation of any Encumbrance upon any of the properties or assets of Company or give to others any rights of termination,
amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any Material Contract (as hereinafter
defined) or (iii) subject to the Required Approvals, result in a violation of any law, rule, regulation, order, judgment,
injunction, decree or other restriction of any court or governmental authority to which Company is subject (including federal and
state securities laws and regulations and the rules and regulations, assuming the correctness of the representations and warranties
made by Purchaser herein, of any self regulatory organization to which Company or its securities are subject), or by which any
property or asset of Company is bound or affected), except in the case of clause (ii) and clause (iii) such as would
not individually have a Material Adverse Effect. “Material Contract” means
any contract of Company that has been filed as an exhibit to the SEC Reports pursuant to Item 601(b)(4) or Item 601(b)(10) of Regulation
S-K (including, for purposes hereof, any contracts that are required to be filed as an exhibit to a Form 10). “Encumbrance”
means any mortgage, deed of trust, pledge, hypothecation, assignment, security interest, lien (whether statutory or otherwise),
charge, claim, encumbrance or preference, priority or other security agreement or preferential arrangement held or asserted in
respect of any asset or property of any kind or nature whatsoever, including any conditional sale or other title retention agreement,
any lease having substantially the same economic effect as any of the foregoing, and the filing of, or agreement to give, any financing
statement under the UCC or comparable law of any jurisdiction.

 

    	4

    	 

    

 

(d)          Company
is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration
with, any court or other federal, state, local or other governmental authority or other person or entity in connection with the
execution, delivery and performance by Company of the transactions contemplated by this Agreement, the Warrant Agreement and any
agreement executed in connection herewith or therewith (including the issuance of the Shares), other than (i) the filing with
the Commission of one or more registration statements, (ii) filings required by applicable state securities laws, (iii) the
filing of a Notice of Sale of Securities on Form D with the Commission under Regulation D of the Securities Act, (iv) filing
of a report on Form 8-K disclosing the Company’s entry into this Agreement and (v) those that have been made or obtained
prior to the date of this Agreement (collectively, the “Required Approvals”).

 

(e)          The
Shares have been duly authorized and, when issued and paid for in accordance with the terms of this Agreement, will be duly and
validly issued, fully paid and nonassessable and free and clear of all Encumbrances suffered or permitted by Company, other than
restrictions on transfer provided for in this Agreement or imposed by applicable securities laws, and shall not be subject to preemptive
or similar rights. Assuming the accuracy of the representations and warranties of Purchaser in this Agreement, the Shares will
be issued in compliance with all applicable federal and state securities laws.

 

(f)          There
are no actions, suits, claims, investigations or other legal proceedings pending or, to the Company’s Knowledge, threatened
against or by Company that challenge or seek to prevent, enjoin or otherwise delay the transactions contemplated by this Agreement.
“Company’s Knowledge” means with respect to any statement made to the knowledge of Company, that the statement
is based upon the actual knowledge of the officers of Company who, as of the date hereof, have responsibility for the matter or
matters that are the subject of the statement.

 

(g)          Company
has filed all reports, schedules, forms, statements and other documents required to be filed by it under the Securities Exchange
Act of 1934, as amended (the “Exchange Act”), including pursuant to Section 13(a) or 15(d) thereof, for twelve
(12) months preceding and including the date hereof (or such shorter period as Company was required by law or regulation to
file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being
collectively referred to herein as the “SEC Reports”), on a timely basis or has received a valid extension of
such time of filing and has filed any such SEC Reports prior to the expiration of any such extension.

 

    	5

    	 

    

 

(h)          The
financial statements of Company included in the SEC Reports comply in all material respects with applicable accounting requirements
and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements
have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) applied on a consistent
basis during the periods involved, except as may be otherwise specified in such financial statements or the notes thereto and except
that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects
the financial position of Company and its consolidated subsidiaries taken as a whole as of and for the dates thereof and the results
of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, year-end audit
adjustments.

 

(i)          Assuming
the accuracy of Purchaser’s representations and warranties set forth in Section 7 of this Agreement (without giving effect
to any materiality qualifiers therein), no registration under the Securities Act is required for the offer and sale of the Shares
by Company to Purchaser under this Agreement.

 

(j)          No
broker, finder or investment banker is entitled to any brokerage, finder's or other fee or commission in connection with the transactions
contemplated by this Agreement based upon arrangements made by or on behalf of Company.

 

		7.	Representation and Warranties of Purchaser.

 

(a)          Purchaser
is a limited liability company duly organized, validly existing and in good standing under the laws of the State of Alaska.

 

(b)          Purchaser
has all requisite power and authority to enter into this Agreement, to carry out its obligations hereunder and to consummate the
transactions contemplated hereby. The execution and delivery by Purchaser of this Agreement, the performance by Purchaser of its
obligations hereunder and the consummation by Purchaser of the transactions contemplated hereby have been duly authorized by all
requisite limited liability company action on the part of Purchaser. This Agreement has been duly executed and delivered by Purchaser
and (assuming due authorization, execution and delivery by Company) this Agreement constitutes a legal, valid and binding obligation
of Purchaser enforceable against Purchaser in accordance with its terms.

 

(c)          Purchaser
is acquiring the Shares solely for its own account for investment purposes and not with a view to, or for offer or sale in connection
with, any distribution thereof. Purchaser acknowledges that the Shares are not registered under the Securities Act, or any state
securities laws, and that the Shares may not be transferred or sold except pursuant to the registration provisions of the Securities
Act or pursuant to an applicable exemption therefrom and subject to state securities laws and regulations, as applicable.

 

    	6

    	 

    

 

(d)          No
governmental, administrative or other third party consents or approvals are required by or with respect to Purchaser in connection
with the execution and delivery of this Agreement and the consummation of the transactions contemplated hereby.

 

(e)          There
are no actions, suits, claims, investigations or other legal proceedings pending or, to the knowledge of Purchaser, threatened
against or by Purchaser that challenge or seek to prevent, enjoin or otherwise delay the transactions contemplated by this Agreement.

 

(f)          Purchaser
understands that the Shares are “restricted securities” and have not been registered under the Securities Act or any
applicable state securities law and is acquiring the Shares as principal for its own account and not with a view to, or for distributing
or reselling such Shares or any part thereof in violation of the Securities Act or any applicable state securities laws, provided,
however, that by making the representations herein, Purchaser does not agree to hold any of the Shares for any minimum period
of time and reserves the right, subject to the provisions of this Agreement, at all times to sell or otherwise dispose of all or
any part of such Shares pursuant to an effective registration statement under the Securities Act or under an exemption from such
registration and in compliance with applicable federal and state securities laws. Purchaser is acquiring the Shares hereunder in
the ordinary course of its business. Purchaser does not presently have any agreement, plan or understanding, directly or indirectly,
with any Person to distribute or effect any distribution of any of the Shares (or any Shares which are derivatives thereof) to
or through any person or entity; Purchaser is not a registered broker-dealer under Section 15 of the Exchange Act or an entity
engaged in a business that would require it to be so registered as a broker-dealer.

 

(g)          At
the time Purchaser was offered the Shares, it was, and at the date hereof it is, an “accredited investor” as defined
in Rule 501(a) under the Securities Act. Purchaser has previously delivered an Accredited Investor Questionnaire to Company indicating
that Purchaser is an “accredited investor.” As of the date of this Agreement, circumstances have not changed such that
Purchaser would not be an “accredited investor.”

 

(h)          Purchaser,
either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial
matters so as to be capable of evaluating the merits and risks of the prospective investment in the Shares, and has so evaluated
the merits and risks of such investment. Purchaser is able to bear the economic risk of an investment in the Shares and, at the
present time, is able to afford a complete loss of such investment.

 

    	7

    	 

    

 

(i)          Purchaser
acknowledges that it has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive
answers from, representatives of Company concerning the terms and conditions of the offering of the Shares and the merits and risks
of investing in the Shares; (ii) access to information about Company and its respective financial condition, results of operations,
business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity
to obtain such additional information that Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment. Neither such inquiries nor any other investigation conducted
by or on behalf of Purchaser or its representatives or counsel shall modify, amend or affect Purchaser’s right to rely on
the truth, accuracy and completeness of Company’s representations and warranties contained in this Agreement. Purchaser has
sought such accounting, legal and tax advice as it has considered necessary to make an informed decision with respect to its acquisition
of the Shares.

 

(j)          Purchaser
understands that the Shares are being offered and sold to it in reliance on specific exemptions from the registration requirements
of United States federal and state securities laws and that Company is relying in part upon the truth and accuracy of, and Purchaser’s
compliance with, the representations, warranties, agreements, acknowledgements and understandings of Purchaser set forth herein
in order to determine the availability of such exemptions and the eligibility of Purchaser to acquire the Shares.

 

(k)          Purchaser
understands that no United States federal or state agency or any other government or governmental agency has passed on or made
any recommendation or endorsement of the Shares or the fairness or suitability of the investment in the Shares nor have such authorities
passed upon or endorsed the merits of the offering of the Shares.

 

(l)          No
broker, finder or investment banker is entitled to any brokerage, finder's or other fee or commission in connection with the transactions
contemplated by this Agreement based upon arrangements made by or on behalf of Purchaser.

 

		8.	Transfer Restrictions.

 

(a)          
Notwithstanding any other provision of this Agreement, Purchaser covenants that the Shares may be disposed of only pursuant to
an effective registration statement under, and in compliance with the requirements of, the Securities Act, or pursuant to an available
exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, and in compliance with
any applicable state and federal securities laws. In connection with any transfer of the Shares other than (i) pursuant to
an effective registration statement, (ii) to Company, (iii) to an affiliate of Purchaser, (iv) pursuant to Rule 144
under the Securities Act (“Rule 144”) (provided that Purchaser provides Company with reasonable assurances
(in the form of seller and broker representation letters if required) that the securities may be sold pursuant to such rule) or
Rule 144A, (v) pursuant to Rule 144 without the requirement that Company be in compliance with the current public information
requirements of Rule 144 and without other restriction following the applicable holding period or (vi) in connection
with a bona fide pledge, Company may require the transferor thereof to provide to Company an opinion of counsel selected by the
transferor and reasonably acceptable to Company, the form and substance of which opinion shall be reasonably satisfactory to Company,
to the effect that such transfer does not require registration of such transferred Shares under the Securities Act. As a condition
of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and shall have the rights of
Purchaser under this Agreement.

 

    	8

    	 

    

 

(b)          Certificates
evidencing the Shares shall bear any legend as required by the “Blue Sky” laws of any state and a restrictive legend
in substantially the following form until such time as they are not required under Section 8(c) (and a stock transfer order
may be placed against transfer of the certificates for the Shares):

 

THESE SECURITIES HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE
SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OR (B) AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION OF COUNSEL REASONABLY SATISFACTORY TO COMPANY.

 

In addition, if Purchaser
is an affiliate of Company, certificates evidencing the Shares issued to Purchaser shall bear a customary “affiliates”
legend.

 

(c)          Subject
to Company’s right to request an opinion of counsel as set forth in Section 8(a), the legend set forth in Section 8(b)
above shall be removable and Company shall issue or cause to be issued a certificate without such legend or any other legend (except
for any “affiliates” legend as set forth in Section 8(b)) to the holder of the applicable Shares upon which it is stamped
if (i) such Shares are registered for resale under the Securities Act (provided that, if Purchaser is selling pursuant to
the effective registration statement registering the Shares for resale, Purchaser agrees to only sell such Shares during such time
that such registration statement is effective and not withdrawn or suspended, and only as permitted by such registration statement),
(ii) such Shares are sold or transferred in compliance with Rule 144 (if the transferor is not an affiliate of Company), including
without limitation in compliance with the current public information requirements of Rule 144 if applicable to Company at the time
of such sale or transfer, and the holder and its broker have delivered customary documents reasonably requested by Company’s
transfer agent and/or Company counsel in connection with such sale or transfer, or (iii) such Shares are eligible for sale under
Rule 144 without the requirement that Company be in compliance with the current public information requirements of Rule 144 and
without other restriction and Company counsel has provided written confirmation of such eligibility to the transfer agent. Any
fees (with respect to the transfer agent, Company counsel or otherwise) associated with the removal of such legend shall be borne
by Company. At such time as a legend is no longer required for certain Shares, Company will no later than three (3) business
days following the delivery by Purchaser to Company or the transfer agent (with concurrent notice and delivery of copies to Company)
of a legended certificate representing such Shares (endorsed or with stock powers attached, signatures guaranteed, and otherwise
in form necessary to affect the reissuance and/or transfer, and together with such other customary documents as the transfer agent
and/or Company counsel shall reasonably request), deliver or cause to be delivered to the transferee of Purchaser or Purchaser,
as applicable, a certificate representing such Shares that is free from all restrictive and other legends. Company may not make
any notation on its records or give instructions to the transfer agent that enlarge the restrictions on transfer set forth in this
Section 8(c).

 

    	9

    	 

    

 

(d)          Purchaser
hereunder acknowledges its primary responsibilities under the Securities Act and accordingly will not sell or otherwise transfer
the Shares or any interest therein without complying with the requirements of the Securities Act. Purchaser acknowledges that the
delivery of the Shares and any removal of any legends from certificates representing the Shares as set forth in this Section 8
is predicated on Company’s reliance upon Purchaser’s acknowledgement in this Section 8(d).

 

9.          Survival.
All representations and warranties contained herein shall survive the execution and delivery of this Agreement and the Closing
hereunder.

 

10.         Indemnification.
Company shall indemnify Purchaser and hold Purchaser harmless against and in respect of any and all losses, liabilities, damages,
obligations, claims, Encumbrances, costs and expenses (including, without limitation, reasonable attorneys' fees) incurred by Purchaser
resulting from any breach of any representation, warranty, covenant or agreement made by Company herein or in any instrument or
document delivered to Purchaser pursuant hereto.

 

11.         Further
Assurances. Following the Closing, each of the parties hereto shall execute and deliver such additional documents, instruments,
conveyances and assurances, and take such further actions as may be reasonably required to carry out the provisions hereof and
give effect to the transactions contemplated by this Agreement.

 

12.         Termination.
This Agreement may be terminated at any time prior to the Closing (a) by the mutual written consent of Purchaser and Company or
(b) by either Purchaser or Company if (i) a breach of any provision of this Agreement has been committed by the other party and
such breach has not been cured within 10 days following receipt by the breaching party of written notice of such breach, or (ii)
the Closing does not occur by July 1, 2015. Upon termination, all further obligations of the parties under this Agreement shall
terminate without liability of any party to the other parties to this Agreement, except that no such termination shall relieve
any party from liability for any fraud or willful breach of this Agreement.

 

    	10

    	 

    

 

13.         Expenses.
The Company agrees to pay all reasonable expenses, including legal fees and disbursements, incurred by Purchaser in connection
with this Agreement, the Warrant Agreement and the transactions contemplated hereby and thereby.

 

14.         Notices.
All notices, requests, consents, claims, demands, waivers and other communications hereunder (each, a "Notice")
shall be in writing and addressed to the parties at the addresses set forth on the first page of this Agreement (or to such other
address that may be designated by the receiving party from time to time in accordance with this section). All Notices shall be
delivered by personal delivery, nationally recognized overnight courier (with all fees pre-paid), facsimile or e-mail of a PDF
document (with confirmation of transmission) or certified or registered mail (in each case, return receipt requested, postage prepaid).
Except as otherwise provided in this Agreement, a Notice is effective only (a) upon receipt by the receiving party, and (b) if
the party giving the Notice has complied with the requirements of this Section.

 

15.         Entire
Agreement. This Agreement constitutes the sole and entire agreement of the parties to this Agreement with respect to the subject
matter contained herein, and supersedes all prior and contemporaneous understandings, agreements, representations and warranties,
both written and oral, with respect to such subject matter.

 

16.         Successor
and Assigns. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective
successors and permitted assigns. No party may assign any of its rights or obligations hereunder without the prior written consent
of the other parties hereto, which consent shall not be unreasonably withheld or delayed.

 

17.         Headings.
The headings in this Agreement are for reference only and shall not affect the interpretation of this Agreement.

 

18.         Amendment
and Modification; Waiver. This Agreement may only be amended, modified or supplemented by an agreement in writing signed by
each party hereto. No waiver by any party of any of the provisions hereof shall be effective unless explicitly set forth in writing
and signed by the party so waiving. Except as otherwise set forth in this Agreement, no failure to exercise, or delay in exercising,
any rights, remedy, power or privilege arising from this Agreement shall operate or be construed as a waiver thereof; nor shall
any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof
or the exercise of any other right, remedy, power or privilege.

 

    	11

    	 

    

 

19.         Severability.
If any term or provision of this Agreement is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality
or unenforceability shall not affect any other term or provision of this Agreement or invalidate or render unenforceable such term
or provision in any other jurisdiction. Upon such determination that any term or other provision is invalid, illegal or unenforceable,
the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as
closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally
contemplated to the greatest extent possible.

 

20.         Governing
Law; Submission to Jurisdiction. This Agreement shall be governed by and construed in accordance with the internal laws of
the State of New York without giving effect to any choice or conflict of law provision or rule (whether of the State of New York
or any other jurisdiction). Any legal suit, action or proceeding arising out of or based upon this Agreement or the transactions
contemplated hereby may be instituted in the federal courts of the United States or the courts of the State of New York in each
case located in the city of New York and County of New York, and each party irrevocably submits to the exclusive jurisdiction of
such courts in any such suit, action or proceeding. Service of process, summons, notice or other document by mail to such party's
address set forth herein shall be effective service of process for any suit, action or other proceeding brought in any such court.
The parties irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or any proceeding in
such courts and irrevocably waive and agree not to plead or claim in any such court that any such suit, action or proceeding brought
in any such court has been brought in an inconvenient forum.

 

21.         Counterparts.
This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed
to be one and the same agreement. A signed copy of this Agreement delivered by facsimile, e-mail or other means of electronic transmission
shall be deemed to have the same legal effect as delivery of an original signed copy of this Agreement.

 

[SIGNATURE PAGE FOLLOWS]

 

    	12

    	 

    

 

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement
on the date first written above.

 

	 	TWINLAB CONSOLIDATED HOLDINGS, INC.
	 	 	 
	 	By:	/s/ Thomas A. Tolworthy 
	 	Name:	Thomas A. Tolworthy
	 	Title:	Chief Executive Officer and President

 

 

	 	JL-BBNC MEZZ UTAH, LLC,
	 	An Alaska limited liability company
	 	 	 
	 	By:	/s/ Jonathan B. Rubini  
	 	Name:  	Jonathan B. Rubini
	 	Title:    	Managing Member

 

    	13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00247-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00247-of-00352.parquet"}]]